
Powering What's Possible | Novavax
Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.
Novavax's COVID-19 Vaccine: Your Questions Answered
May 20, 2025 · The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine …
Novavax COVID-19 vaccine - Wikipedia
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for …
FDA Approves Novavax COVID Vaccine With Restricted Use
May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it.
Novavax COVID-19 Vaccine Summary | Vaccines & Immunizations …
Sep 10, 2024 · Novavax COVID-19 Vaccine, Adjuvanted is indicated for individuals 12 years of age and older. Novavax's product will be presented in prefilled syringes, and there is one …
Novavax’s R&D Shift and Sanofi Partnership Could Be a Game …
Nov 26, 2025 · Novavax, Inc. recently announced at the Jefferies London Healthcare Conference 2025 that it is shifting its focus from direct COVID-19 commercial operations to an expanded …
FDA Authorizes Updated Novavax COVID-19 Vaccine to Better …
As part of today’s action, the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) is no longer authorized for use.
Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine …
Aug 27, 2025 · Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including …
Novavax COVID Vaccine: Side Effects, Eligibility, And More - GoodRx
Oct 13, 2025 · The Novavax COVID vaccine uses more conventional vaccine technology compared to the Pfizer and Moderna vaccines. It provides an option for people who can’t or …
Novavax - Wikipedia
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company's first and only commercial product is the Novavax COVID-19 vaccine.